MedPath

Termination of Persistent Atrial Fibrillation by Catheter Ablation

Conditions
Atrial Fibrillation
Interventions
Procedure: Catheter ablation
Registration Number
NCT04958928
Lead Sponsor
Shanghai Chest Hospital
Brief Summary

This is a prospective, multicenter, cohort study aims to demonstrate the role of termination of AF in ablation for persistent atrial fibrillation, and evaluate the clinical outcomes in patients with or without AF termination.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  1. Aged 18 to 80 years old; 2. Persistent AF; 3. Nonresponse or intolerance to ≥1 antiarrhythmic drug.
Exclusion Criteria
  1. With uncontrolled congestive heart failure;

  2. Having significant valvular disease and/or prosthetic heart valve(s);

  3. With myocardial infarction or stroke within 6 months of screening;

  4. With Significant congenital heart disease;

  5. Ejection fraction was <40% measured by echocardiography;

  6. Allergic to contrast media;

  7. Contraindication to anticoagulation medications;

  8. Severe pulmonary disease e.g. restrictive pulmonary disease, chronic obstructive disease (COPD);

  9. Left atrial (LA) thrombus measured by pre-procedure transesophageal echocardiography;

  10. Having any contraindication to right or left sided heart catheterization; 11. Previous atrial fibrillation ablation;

  11. Presence of an implanted cardioverter-defibrillator; 13. Any cardiac surgery within the past 2 months; 14. Poor general health; 15.Life expectancy less than 6 months.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Persistent AF GroupCatheter ablation-
Primary Outcome Measures
NameTimeMethod
AF recurrence rate12 months

AF recurrence is defined as presence of documented AF episodes of 30 recurrence is defined as presence of documented AF episodes of 30 seconds or longer duration.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath